Effect of age on the efficacy and safety of lenvatinib for the treatment of 131i-refractory differentiated thyroid cancer in the phase 3 select study
Titel:
Effect of age on the efficacy and safety of lenvatinib for the treatment of 131i-refractory differentiated thyroid cancer in the phase 3 select study
Auteur:
Brose, M. Schlumberger, M. Tahara, M. Wirth, L.J. Robinson, B. Elisei, R. Newbold, K. Kiyota, N. Hoff, A.O. Dutcus, C.E. Heras, B.D.L. Zhu, J. Sherman, S.I. Taylor, M.